FDA Adverse Event Malfunction Summary report: N

SYRINGE 5ML LL EURO 125 S/C

MDR report key: 11803333 · Received May 10, 2021

Report

Report Number
1213809-2021-00302
Event Type
Malfunction
Date Received
May 10, 2021
Date of Event
April 12, 2021
Report Date
May 26, 2021
Manufacturer
BECTON DICKINSON MEDICAL SYSTEMS
Product Code
FMF
UDI-DI
00382903096497
PMA / PMN Number
K980987
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: ONE PHOTO AND THREE LOOSE 5ML SYRINGES WITH BLISTER PACKS FROM BATCH 0213256 (P/N 309649) WERE RECEIVED AND EVALUATED. IT WAS OBSERVED ALL THREE OF THE SYRINGES EACH HAD SINGLE LENGTHWISE CRACK IN THE BARREL WALL EXTENDING FROM APPROXIMATELY THE 1ML TO 4ML MARKING. POTENTIAL ROOT CAUSE FOR THE CRACKED BARREL DEFECT IS ASSOCIATED WITH THE ASSEMBLY PROCESS. A DEVICE HISTORY RECORD REVIEW SHOWED NO REJECTED INSPECTIONS OR QUALITY ISSUES DURING THE PRODUCTION OF THE PROVIDED LOT NUMBER THAT COULD HAVE CONTRIBUTED TO THE REPORTED DEFECT.

Description of Event or Problem · 0

IT WAS REPORTED THAT SYRINGE 5ML LL EURO 125 S/C WAS DAMAGED. THIS OCCURRED ON 3 OCCASIONS. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 3 L.L. 5ML SYRINGES WITH CRACKS. THE DEVICES WERE NOT IN CONTACT WITH A TOXIC SUBSTANCE. CIRCUMSTANCES / DESCRIPTION: WHEN COLLECTING PPI WATER TO REPLENISH VIDAZA VIALS: OBSERVATION OF 3 SYRINGES WITH CRACKED BODIES. NO CLINICAL CONSEQUENCES FOR PATIENT OR OPERATOR. PRECAUTIONARY MEASURES AND ACTIONS TAKEN: QUARANTINE OF CRACKED SYRINGES, USE OF NEW 5ML SYRINGES.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT SYRINGE 5ML LL EURO 125 S/C WAS DAMAGED. THIS OCCURRED ON 3 OCCASIONS. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 3 L.L. 5ML SYRINGES WITH CRACKS. THE DEVICES WERE NOT IN CONTACT WITH A TOXIC SUBSTANCE. CIRCUMSTANCES / DESCRIPTION: WHEN COLLECTING PPI WATER TO REPLENISH VIDAZA VIALS: OBSERVATION OF 3 SYRINGES WITH CRACKED BODIES. NO CLINICAL CONSEQUENCES FOR PATIENT OR OPERATOR. PRECAUTIONARY MEASURES AND ACTIONS TAKEN: QUARANTINE OF CRACKED SYRINGES, USE OF NEW 5ML SYRINGES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
694953 SYRINGE 5ML LL EURO 125 S/C PISTON SYRINGE FMF BECTON DICKINSON MEDICAL SYSTEMS 0213256 00382903096497

Patients

Seq Age Sex Outcome Treatment
1